Aethlon Medical Current Ratio 2010-2024 | AEMD

Aethlon Medical current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aethlon Medical Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $0.01B $0.00B 3.06
2024-06-30 $0.01B $0.00B 4.49
2024-03-31 $0.01B $0.00B 3.40
2023-12-31 $0.01B $0.00B 3.93
2023-09-30 $0.01B $0.00B 6.13
2023-06-30 $0.01B $0.00B 7.31
2023-03-31 $0.02B $0.00B 10.03
2022-12-31 $0.02B $0.00B 7.46
2022-09-30 $0.02B $0.00B 9.76
2022-06-30 $0.02B $0.00B 9.66
2022-03-31 $0.02B $0.00B 9.95
2021-12-31 $0.02B $0.00B 19.83
2021-09-30 $0.02B $0.00B 24.19
2021-06-30 $0.03B $0.00B 22.58
2021-03-31 $0.01B $0.00B 7.53
2020-12-31 $0.01B $0.00B 9.97
2020-09-30 $0.02B $0.00B 9.90
2020-06-30 $0.02B $0.00B 13.16
2020-03-31 $0.01B $0.00B 9.40
2019-12-31 $0.00B $0.00B 5.31
2019-09-30 $0.00B $0.00B 0.77
2019-06-30 $0.00B $0.00B 1.47
2019-03-31 $0.00B $0.00B 2.21
2018-12-31 $0.01B $0.00B 2.73
2018-09-30 $0.01B $0.00B 4.10
2018-06-30 $0.01B $0.00B 13.45
2018-03-31 $0.01B $0.00B 15.13
2017-12-31 $0.01B $0.00B 16.72
2017-09-30 $0.00B $0.00B 2.93
2017-06-30 $0.00B $0.00B 0.90
2017-03-31 $0.00B $0.00B 2.61
2016-12-31 $0.00B $0.00B 1.77
2016-09-30 $0.00B $0.00B 0.75
2016-06-30 $0.00B $0.00B 2.81
2016-03-31 $0.00B $0.00B 4.51
2015-12-31 $0.00B $0.00B 3.89
2015-09-30 $0.01B $0.00B 5.49
2015-06-30 $0.01B $0.00B 6.48
2015-03-31 $0.00B $0.00B 2.10
2014-12-31 $0.00B $0.00B 1.86
2014-09-30 $0.00B $0.00B 0.26
2014-06-30 $0.00B $0.00B 0.26
2014-03-31 $0.00B $0.02B 0.10
2013-12-31 $0.00B $0.01B 0.15
2013-09-30 $0.00B $0.01B 0.02
2013-06-30 $0.00B $0.01B 0.01
2013-03-31 $0.00B $0.01B 0.04
2012-12-31 $0.00B $0.01B 0.02
2012-09-30 $0.00B $0.01B 0.04
2012-06-30 $0.00B $0.01B 0.07
2012-03-31 $0.00B $0.01B 0.07
2011-12-31 $0.00B $0.01B 0.11
2011-09-30 $0.00B $0.01B 0.03
2011-06-30 $0.00B $0.01B 0.02
2011-03-31 $0.00B $0.01B 0.06
2010-12-31 $0.00B $0.01B 0.08
2010-09-30 $0.00B $0.01B 0.11
2010-06-30 $0.00B $0.01B 0.08
2010-03-31 $0.00B $0.01B 0.04
2009-12-31 $0.00B $0.00B 0.02
2009-09-30 $0.00B $0.00B 0.03
2009-06-30 $0.00B $0.00B 0.04
2009-03-31 $0.00B $0.00B 0.01
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.005B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $520.136B 20.92
Cigna Group (CI) United States $86.608B 11.33
Humana (HUM) United States $34.416B 15.67
Centene (CNC) United States $28.631B 8.40
Molina Healthcare (MOH) United States $17.058B 13.57
Select Medical Holdings (SEM) United States $2.578B 8.93
Joint (JYNT) United States $0.175B 106.09